Suchergebnisse - (Standardsuche:"novel coronavirus" OR Covid OR "Sars-CoV" OR "CoV-2" OR ncov)

PubPharm (980)

361

The future is now: our experience starting a remote clinical trial during the beginning of the COVID-19 pandemic

in: Trials | 2021

von Hans H. Liu | Michael D. Ezekowitz | Michele Columbo | +6

362

Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised controlled trial

in: Trials | 2021

von Shoaib Ashraf | Sohaib Ashraf | Iqra Farooq | +29

363

Accelerated first-in-human clinical trial of EIDD-2801/MK-4482 (molnupiravir), a ribonucleoside analog with potent antiviral activity against SARS-CoV-2

in: Trials | 2021

von Wendy Holman | Wayne Holman | Stacy McIntosh | +4

364

The impact of theory-based messages on COVID-19 vaccination intentions: a structured summary of a study protocol for a randomised controlled trial

in: Trials | 2021

von Ben Young | Marie Kotzur | Lauren Gatting | +7

365

Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study

in: Trials | 2021

von John P. Haran | Jose C. Pinero | Yan Zheng | +2

366

Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations

in: Trials | 2021

von Lakshmi Manoharan | Piero Olliaro | Peter W. Horby | +1

367

The UPTAKE study: implications for the future of COVID-19 vaccination trial recruitment in UK and beyond

in: Trials | 2021

von Sonika Sethi | Aditi Kumar | Anandadeep Mandal | +6

368

Effect of dexamethasone in patients with ARDS and COVID-19 – prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial

in: Trials | 2021

von Jan Maláska | Jan Stašek | František Duška | +17

369

Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial

in: Trials | 2021

von Benjamin Gaborit | Bernard Vanhove | Marie-Anne Vibet | +21

370

Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults

in: Trials | 2021

von Wesley H. Self | Thomas G. Stewart | Allison P. Wheeler | +44